Physician profile
Seth Bernard
NPI 1720047889
$759.92
in general payments reported to CMS, 2019-2025
15 companies · $21.73 in 2025
The $21.73 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $246 · 2021: $77.91 · 2023: $99.44 · 2024: $43.60 · 2025: $21.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $277.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $88.45 | 2020 | |
| Abbvie INC. | $81.14 | 2023-2024 | Linzess |
| Glaxosmithkline, LLC. | $77.91 | 2021 | |
| Exact Sciences Corporation | $43.17 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $37.88 | 2019-2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $32.53 | 2019 | |
| Astellas Pharma US INC | $26.19 | 2019 | |
| Merck Sharp & Dohme LLC | $16.52 | 2024 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.02 | 2019 | |
| Philips North America LLC | $14.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.36 | 2019 | |
| Lilly USA, LLC | $12.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.